Victoria Forster, PhD

Victoria Forster is a postdoctoral research scientist and freelance science writer. Her research interests include; DNA repair deficiencies, pediatric cancers, stem cell and organoid models for cancer development and cancer treatment-related side effects. She is also a 25-year survivor of childhood leukemia and an advocate for childhood cancer awareness. She has bylines in several outlets including The Times, The Guardian, Forbes, and Cancer Therapy Advisor.

All articles by Victoria Forster, PhD

Urology

Lack of Mask Mandates Leaves Cancer Patients Feeling Unprotected

Victoria Forster, PhD

July 22, 2022

Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.

Prostate Cancer

Risk of Cancer-Specific Death May Remain Elevated for 30 Years

Victoria Forster, PhD

May 24, 2022

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.

Kidney Cancer

Many Immune Checkpoint Inhibitor Combination Therapies Show No Evidence of Drug Synergy

Victoria Forster, PhD

February 11, 2022

The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.

Prostate Cancer

Docs Disagree With Update to NCCN Guidelines for Prostate Cancer

Victoria Forster, PhD

October 29, 2021

An update to active surveillance recommendations has some physicians concerned.

Prostate Cancer

Ipilimumab May Help Some Patients With Prostate Cancer—Even Those With Low TMB

Victoria Forster, PhD

May 6, 2020

A trial in phase 2 metastatic prostate cancer shows that some patients likely to benefit from ipilimumab treatment, even with low number of tumor mutations.